Yunfei Yuan

25PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersTumour immunologyHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 18, 2026
HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation-Mediated TXNRD1 Stabilization to Suppress Ferroptosis.

|Apr 20, 2026
SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance.

|Sep 25, 2024
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial.

Yichuan Yuan, Hong Peng, Wei He

|Sep 10, 2024
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling.

Yunxing Shi, Zongfeng Wu, Shaoru Liu

|May 08, 2024
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study.

Liang Qiao, Wei He, Guoying Wang

|Nov 28, 2023
METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition.

Fangfang Bi, Yuxiong Qiu, Zongfeng Wu

Pageof 5

Frequent Collaborators

6 joint publications

Binkui Li

5 joint publications

Yun Zheng

4 joint publications

Binkui Li

4 joint publications

Wei He